Using a novel in vivo research model containing human lung tissue, scientists have demonstrated that a broad spectrum, experimental drug EIDD-2801 proved dramatically...
A new study suggests that those who recover from COVID-19 are protected against SARS-CoV-2 for at least six months and likely much longer due to continually...